Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Gebro Pharma GmbH |
---|---|
Information provided by: | Gebro Pharma GmbH |
ClinicalTrials.gov Identifier: | NCT00442585 |
The purpose of this clinical trial is to determine whether S(+)-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions.
Condition | Intervention | Phase |
---|---|---|
Drug Interactions |
Drug: S(+)-ibuprofen |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Pharmacodynamics Study |
Official Title: | Double Blind, Randomised, Parallel Group, Placebo Controlled Clinical Trial of S(+)-Ibuprofen Effects on TxB2 Concentrations and Platelet Aggregation in Aspirin-Treated Healthy Adult Volunteers |
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Austria | |
Department of Clinical Pharmacology, Medical University Vienna | |
Vienna, Austria, 1090 |
Principal Investigator: | Christian Joukhadar, MD | Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical Univerisity of Vienna |
Study ID Numbers: | Gebro-I-24-13, EUDRACT 2006-002159-33 |
Study First Received: | March 1, 2007 |
Last Updated: | March 1, 2007 |
ClinicalTrials.gov Identifier: | NCT00442585 |
Health Authority: | Austria: Agency for Health and Food Safety |
Ibuprofen Aspirin Healthy |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Cyclooxygenase Inhibitors Enzyme Inhibitors Pharmacologic Actions Analgesics, Non-Narcotic |
Sensory System Agents Therapeutic Uses Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |